CN Patent

CN101998857A — 使用捕水剂的湿式造粒法

Assigned to Rigel Pharmaceuticals Inc · Expires 2011-03-30 · 15y expired

What this patent protects

本发明公开了一种片剂，所述片剂包含(6-(5-氟-2(3，4，5-三甲氧基苯基氨基)嘧啶-4-基氨基)-2，2-二甲基-3-氧-2H-吡啶[3，2-b][1，4]噁嗪-4(3H)-基)甲基磷酸二钠盐(化合物1)的通过湿式造粒法制备的水解稳定性制剂。

USPTO Abstract

本发明公开了一种片剂，所述片剂包含(6-(5-氟-2(3，4，5-三甲氧基苯基氨基)嘧啶-4-基氨基)-2，2-二甲基-3-氧-2H-吡啶[3，2-b][1，4]噁嗪-4(3H)-基)甲基磷酸二钠盐(化合物1)的通过湿式造粒法制备的水解稳定性制剂。

Drugs covered by this patent

fostamatinib-disodium (FOSTAMATINIB DISODIUM)

Patent Metadata

Patent number: CN101998857A
Jurisdiction: CN
Classification: —
Expires: 2011-03-30
Drug substance claim: No
Drug product claim: No
Assignee: Rigel Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.